Found 11 articles for: "Hyperpigmentation"
Isobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies
November 2024 | Volume 23 | Issue 11 | Original Article | 986 | Copyright © November 2024
Background: Tyrosinase is the rate-limiting enzyme of melanogenesis and thus an ideal inhibitory target for treating hyperpigmentation. There are many commercially available tyro...
Read MoreA Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial Hyperpigmentation
November 2024 | Volume 23 | Issue 11 | Original Article | 943 | Copyright © November 2024
Background: Facial hyperpigmentation, characterized by the excessive production of melanin in the skin, is a prevalent dermatological concern affecting individuals of various eth...
Read MoreExamining Racial Diversity in Hyperpigmentation and Post-Inflammatory Hyperpigmentation Clinical Trials in the United States
July 2024 | Volume 23 | Issue 7 | Editorials | e158 | Copyright © July 2024
Postinflammatory Hyperpigmentation Following Mohs Micrographic Surgery: An Observational Study
May 2024 | Volume 23 | Issue 5 | Original Article | 316 | Copyright © May 2024
Importance: Functional and cosmetic outcomes following Mohs micrographic surgery (MMS) are poorly studied in individuals with skin of color (SOC). Postinflammatory hyperpigmentat...
Read MoreComparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness
January 2024 | Volume 23 | Issue 1 | Original Article | 1260 | Copyright © January 2024
Dyschromia is the result of irregular facial pigmentation. These cutaneous manifestations can have a significant impact on the quality of life of those affected, especially among females and skin...
Read MoreTopical Treatments for Melasma and Post-inflammatory Hyperpigmentation
November 2023 | Volume 22 | Issue 11 | Original Article | 1118 | Copyright © November 2023
Background: Dyschromia is one of the most common reasons for patients to seek dermatological care, especially among individuals with skin of color. Most cases present as melasma ...
Read MoreSeasonal Patterns in Tetracycline-Associated Hyperpigmentation Among Patients With Acne Vulgaris
November 2023 | Volume 22 | Issue 11 | Features | e9 | Copyright © November 2023
Background: Oral tetracyclines (TCNs) are commonly prescribed for acne, but they have been shown to increase the risk of hyperpigmentation, particularly in the setting of sun exp...
Read MoreAssessment of Circadian-based Antioxidants Plus a Comprehensive Brightener in Skin of Color Patients With Hyperpigmentation
April 2022 | Volume 21 | Issue 4 | Original Article | 376 | Copyright © April 2022
Background: Hyperpigmentation disorders disproportionately affect individuals with skin of color. There is an unmet need for safe and effective topical treatments for this population....
Read MoreGetting to the Core of Contemporary Therapies for Post-Inflammatory Hyperpigmentation
March 2022 | Volume 21 | Issue 3 | Original Article | 276 | Copyright © March 2022
Post-inflammatory hyperpigmentation (PIH) is a typical complication of inflammatory dermatoses that more frequently and severely affects people with darker skin. External insults to the skin, such as ...
Read MoreHistopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation
February 2022 | Volume 21 | Issue 2 | Original Article | 141 | Copyright © February 2022
Background: Malassezin is a natural indole compound produced by the fungus Malassezia furfur and preclinical investigations have demonstrated an ability to suppress melanogen...
Read MoreThe Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation
March 2021 | Volume 20 | Issue 3 | Editorials | 344 | Copyright © March 2021
The risk of post-inflammatory hyperpigmentation (PIH) in patients undergoing dermatologic procedures is well known. It is especially common after laser procedures and chemical peels but can be seen wi...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
